Regeneron Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
REGN
CUSIP
75886F107
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q4 153 1.39 M $1.05 B
2025 Q3 1,310 91.1 M $51.2 B
2025 Q2 1,284 90.5 M $47.5 B
2025 Q1 1,361 92.3 M $58.5 B
2024 Q4 1,408 93.5 M $66.6 B
2024 Q3 1,475 102 M $106 B
2024 Q2 1,414 104 M $109 B
2024 Q1 1,401 104 M $99.3 B
2023 Q4 1,354 100 M $88.0 B
2023 Q3 1,254 91.3 M $75.1 B
2023 Q2 1,236 92.6 M $66.1 B
2023 Q1 1,261 99.1 M $76.1 B
2022 Q4 1,224 99.2 M $70.8 B
2022 Q3 1,151 93.4 M $64.3 B
2022 Q2 1,124 93.4 M $55.2 B
2022 Q1 1,160 92.9 M $64.8 B
2021 Q4 1,146 90.8 M $57.3 B
2021 Q3 1,082 90.3 M $54.5 B
2021 Q2 1,032 89.2 M $49.7 B
2021 Q1 978 89.7 M $42.4 B
2020 Q4 974 91.5 M $44.8 B
2020 Q3 970 92.4 M $51.8 B
2020 Q2 994 93.1 M $58.0 B
2020 Q1 887 76.1 M $37.1 B
2019 Q4 765 75.3 M $28.3 B
2019 Q3 694 74.5 M $20.6 B
2019 Q2 740 74.6 M $23.3 B
2019 Q1 784 74.1 M $30.4 B
2018 Q4 735 74.4 M $27.8 B
2018 Q3 722 75.2 M $30.4 B
2018 Q2 691 73.3 M $25.3 B
2018 Q1 690 73.6 M $25.3 B
2017 Q4 711 71.6 M $26.9 B
2017 Q3 675 72.4 M $32.4 B
2017 Q2 667 73.1 M $35.9 B
2017 Q1 643 72.3 M $28.0 B
2016 Q4 648 72.2 M $26.5 B
2016 Q3 615 73.6 M $29.6 B
2016 Q2 604 72.6 M $25.4 B
2016 Q1 595 79.7 M $26.2 B
2015 Q4 634 73.9 M $42.5 B
2015 Q3 609 75.4 M $37.1 B
2015 Q2 587 73.9 M $37.7 B
2015 Q1 544 73.1 M $33.0 B
2014 Q4 559 72.8 M $30.0 B
2014 Q3 508 71.7 M $27.9 B
2014 Q2 481 75.2 M $21.6 B
2014 Q1 488 73.5 M $22.3 B